Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
BMJ Open
|
June 25, 2021
Cohort profile: the MUNICH Preterm and Term Clinical study (MUNICH-PreTCl), a neonatal birth cohort with focus on prenatal and postnatal determinants of infant and childhood morbidity
Susanne Pangratz-Fuehrer, Orsolya Genzel-Boroviczény, Wolfgang Emanuel Bodensohn, et al.
ESMO Open
|
March 6, 2022
MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapy
R Bodensohn, R Forbrig, S Quach, et al.
Clinical and Translational Radiation Oncology
|
December 20, 2023
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
Raphael Bodensohn, Daniel F Fleischmann, Sebastian H Maier, et al.
Clinical and Translational Radiation Oncology
|
June 8, 2026
Postoperative fractionated stereotactic radiotherapy for completely resected brain metastases with 25 Gy in five fractions: A single-center retrospective study
Sebastian H Maier, Alexander Nitschmann, Diana-Coralia Dehelean, et al.
Neuro-Oncology Practice
|
May 14, 2026
End-of-life challenges in neuro-oncological patient care: A survey from the Junge Neuroonkologische Arbeitsgemeinschaft
Lazaros Lazaridis, Niklas Benedikt Pepper, Paula Klein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 9, 2025
Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma - Results from a large multicenter analysis of the German Society of Radiation Oncology's Neuro-Radio-Oncology Working Group (DEGRO AG-NRO)
Sina Heider, Luisa Allwohn, Alexander Rühle, et al.
Journal for Immunotherapy of Cancer
|
October 3, 2025
Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter study
Simone Ferdinandus, Alexander Rühle, Allison Lamrani, et al.
Clinical and Translational Radiation Oncology
|
March 12, 2026
Radiotherapy in patients with NSCLC developing progressive disease during immune checkpoint inhibition: Abscopal responses and survival
Justus Kaufmann, Maike Trommer, Alexander Rühle, et al.
Oncoimmunology
|
January 12, 2026
Radiotherapy-induced abscopal effects in immune checkpoint inhibitor-refractory metastatic disease: results from a large multicenter real-world cohort study
Maike Trommer, Alexander Rühle, Allison Lamrani, et al.
Neuro-Oncology Advances
|
March 24, 2026
Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort
David Rieger, Hannes Becker, Bianca Walter, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
BMJ Open
|
June 25, 2021
Cohort profile: the MUNICH Preterm and Term Clinical study (MUNICH-PreTCl), a neonatal birth cohort with focus on prenatal and postnatal determinants of infant and childhood morbidity
Susanne Pangratz-Fuehrer, Orsolya Genzel-Boroviczény, Wolfgang Emanuel Bodensohn, et al.
ESMO Open
|
March 6, 2022
MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapy
R Bodensohn, R Forbrig, S Quach, et al.
Clinical and Translational Radiation Oncology
|
December 20, 2023
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
Raphael Bodensohn, Daniel F Fleischmann, Sebastian H Maier, et al.
Clinical and Translational Radiation Oncology
|
June 8, 2026
Postoperative fractionated stereotactic radiotherapy for completely resected brain metastases with 25 Gy in five fractions: A single-center retrospective study
Sebastian H Maier, Alexander Nitschmann, Diana-Coralia Dehelean, et al.
Neuro-Oncology Practice
|
May 14, 2026
End-of-life challenges in neuro-oncological patient care: A survey from the Junge Neuroonkologische Arbeitsgemeinschaft
Lazaros Lazaridis, Niklas Benedikt Pepper, Paula Klein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 9, 2025
Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma - Results from a large multicenter analysis of the German Society of Radiation Oncology's Neuro-Radio-Oncology Working Group (DEGRO AG-NRO)
Sina Heider, Luisa Allwohn, Alexander Rühle, et al.
Journal for Immunotherapy of Cancer
|
October 3, 2025
Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter study
Simone Ferdinandus, Alexander Rühle, Allison Lamrani, et al.
Clinical and Translational Radiation Oncology
|
March 12, 2026
Radiotherapy in patients with NSCLC developing progressive disease during immune checkpoint inhibition: Abscopal responses and survival
Justus Kaufmann, Maike Trommer, Alexander Rühle, et al.
Oncoimmunology
|
January 12, 2026
Radiotherapy-induced abscopal effects in immune checkpoint inhibitor-refractory metastatic disease: results from a large multicenter real-world cohort study
Maike Trommer, Alexander Rühle, Allison Lamrani, et al.
Neuro-Oncology Advances
|
March 24, 2026
Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort
David Rieger, Hannes Becker, Bianca Walter, et al.
Page
of 6